THIRD HARMONIC BIO INC. - COMMON STOCK

Third Harmonic Bio Announces Stockholder Approval of Plan of Liquidation and Dissolution, Updated THB335 Phase 1 Clinical Data, and Initiation of Sale of THB335

12 Jun 2025 05:00:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces Plan of Liquidation and Dissolution

14 Apr 2025 03:45:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results

27 Mar 2025 05:10:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update

11 Feb 2025 04:00:00 By Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference

25 Nov 2024 13:00:00 By Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in Upcoming Investor Conferences in November

07 Nov 2024 13:00:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces Third Quarter 2024 Financial Results

07 Nov 2024 05:10:00 By Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in Upcoming Investor Conferences in September

10 Sep 2024 13:00:00 By Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in Upcoming Investor Conferences

26 Aug 2024 13:00:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update

08 Aug 2024 05:05:00 By Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference

28 May 2024 13:05:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update

15 May 2024 05:05:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors

28 Mar 2024 05:30:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results

26 Mar 2024 05:05:00 By Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference

26 Feb 2024 13:00:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update

04 Jan 2024 05:00:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces Third Quarter 2023 Financial Results

09 Nov 2023 05:30:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces Leadership Changes

31 Oct 2023 05:30:00 By Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference

31 Aug 2023 05:30:00 By Nasdaq GlobeNewswire

Third Harmonic Bio Announces Second Quarter 2023 Financial Results

10 Aug 2023 05:10:00 By Nasdaq GlobeNewswire